Edition:
United States

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

115.33USD
15 Jun 2018
Change (% chg)

-- (--)
Prev Close
$115.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
88,586
52-wk High
$122.43
52-wk Low
$32.20

Chart for

About

Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company. The Company uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for the treatment of viral infections and liver diseases. Its research and development programs are focused on three disease targets:... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $2,222.13
Shares Outstanding(Mil.): 19.27
Dividend: --
Yield (%): --

Financials

  ENTA.OQ Industry Sector
P/E (TTM): 42.25 240.92 34.18
EPS (TTM): 2.73 -- --
ROI: 18.48 -5.87 13.17
ROE: 18.73 -7.71 15.15

BRIEF-Enanta Pharmaceuticals Reports Q2 Earnings Per Share $0.61

* ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL SECOND QUARTER ENDED MARCH 31, 2018

May 08 2018

BRIEF-Enanta Pharmaceuticals Reports Q1 Earnings Per Share $0.59

* ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS FISCAL FIRST QUARTER ENDED DECEMBER 31, 2017

Feb 07 2018

BRIEF-Enanta Pharmaceuticals Says Phase 1 Clinical Study Of Edp-938 For Respiratory Syncytial Virus Initiated

* ENANTA PHARMACEUTICALS TO PROVIDE UPDATES ON ITS RESEARCH AND DEVELOPMENT PROGRAMS AND BUSINESS OUTLOOK FOR 2018 DURING THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Jan 05 2018

Earnings vs. Estimates